204 related articles for article (PubMed ID: 11812078)
1. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.
Brummer O; Böhmer G; Hollwitz B; Flemming P; Petry KU; Kühnle H
Gynecol Oncol; 2002 Feb; 84(2):222-7. PubMed ID: 11812078
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Weis B; Ben-Baruch G; Reich R
Gynecol Oncol; 1999 Mar; 72(3):380-6. PubMed ID: 10053110
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Anticancer Res; 2006; 26(2B):1543-56. PubMed ID: 16619570
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry.
Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):109-14. PubMed ID: 9481557
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma.
Gaiotto MA; Focchi J; Ribalta JL; Stávale JN; Baracat EC; Lima GR; Guerreiro da Silva ID
Am J Obstet Gynecol; 2004 May; 190(5):1278-82. PubMed ID: 15167830
[TBL] [Abstract][Full Text] [Related]
6. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation.
Talvensaari A; Apaja-Sarkkinen M; Höyhtyä M; Westerlund A; Puistola U; Turpeenniemi T
Gynecol Oncol; 1999 Mar; 72(3):306-11. PubMed ID: 10053100
[TBL] [Abstract][Full Text] [Related]
8. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix.
Nasr M; Ayyad SB; El-Lamie IK; Mikhail MY
Eur J Gynaecol Oncol; 2005; 26(2):199-202. PubMed ID: 15857029
[TBL] [Abstract][Full Text] [Related]
10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
11. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
[TBL] [Abstract][Full Text] [Related]
12. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
13. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
15. Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix.
Minami R; Tsunoda H; Iijima T; Yoshikawa H; Nemori R; Noguchi M
Mod Pathol; 2003 Nov; 16(11):1164-70. PubMed ID: 14614057
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.
Lai HC; Chu CM; Lin YW; Chang CC; Nieh S; Yu MH; Chu TY
Gynecol Oncol; 2005 Feb; 96(2):314-9. PubMed ID: 15661214
[TBL] [Abstract][Full Text] [Related]
17. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Ben-Baruch G; Reich R
Gynecol Oncol; 1999 Jun; 73(3):372-82. PubMed ID: 10366463
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
19. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities.
Hopman AH; Smedts F; Dignef W; Ummelen M; Sonke G; Mravunac M; Vooijs GP; Speel EJ; Ramaekers FC
J Pathol; 2004 Jan; 202(1):23-33. PubMed ID: 14694518
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
